Home / Acrivon Therapeutics, Inc. (ACRV)

Updated: 2026-03-17 00:39 UTC · Last close: 1.70 (+4.94%)

Acrivon Therapeutics, Inc. (ACRV) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.

The latest close for Acrivon Therapeutics, Inc. (ACRV) came in at 1.70 (+4.94%). The chart is still trading below both the 50-day and 200-day moving averages, leaving the overall technical backdrop under pressure for now. 20-day momentum is positive at +4.29%; price is trading in the lower part of its roughly 52-week range (1.05–5.61); and ATR14 volatility is elevated at roughly 8.74% of price. RSI(14) stands around 51.7, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram is positive and expanding, pointing to improving upside momentum. Near-term structure is defined by support at 1.43 and resistance at 1.77. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Net income: -58.92M · EPS (basic): -1.53. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

OPEN FULL INTERACTIVE ANALYSIS

Note: This is an algorithmic technical snapshot (not financial advice).

ACRV Chart